Filing Details

Accession Number:
0001209191-21-016886
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-03 16:37:25
Reporting Period:
2021-03-01
Accepted Time:
2021-03-03 16:37:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
718937 Staar Surgical Co STAA Ophthalmic Goods (3851) 953797439
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1781825 K. Jon Hayashida 25651 Atlantic Ocean Drive
Lake Forest CA 92630
Vp, Global Clinical, Medical No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-01 16,000 $35.98 26,794 No 4 M Direct
Common Stock Disposition 2021-03-01 16,000 $105.43 10,794 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Options Disposition 2021-03-01 16,000 $0.00 16,000 $35.98
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,026 2020-03-14 2029-03-13 No 4 M Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.86 to $106.19, inclusive.
  2. The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2023.